Alzheimer – pharma.markets

Roche Alzheimer’s disease Cerebrospinal Fluid (CSF) assays receive FDA clearance, supporting more accurate and timely diagnosis

08/12/2022 MaP 0

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys® Phospho-Tau (181P) CSF (pTau181) assays have received […]

Brainreader and Phenome Health Nearing Exclusive Relationship

30/11/2022 MaP 0

Negotiations Continue as Million Person Trial design advances Brainreader Inc. announced today that it is in advanced negotiations to utilize its Neuroreader® software as the […]

KalGene Pharmaceuticals Inc. an Alzheimer’s focused company using a next generation engineered drug candidate, has appointed new leadership

05/08/2021 MaP 0

Mr. Anthony J. Giovinazzo joins as Executive Chairman; and Dr. Nickolay V. Kukekov, Ph.D. as President and CEO KalGene also announced that concurrent with the […]